I cried with every single patient,” Sung says. “It just was this crazy feeling that, for the patients and families, almost can’t feel real.” The treatment, known as AMT-130, is delivered deep into the ...
Telix Pharmaceuticals Limited (NASDAQ:TLX) is among the best stocks with the highest upside potential. On September 10, 2025, ...
Groundbreaking study demonstrates that targeted oligodendrocyte gene therapy leads to decreased N-acetylaspartate (NAA) ...
Stockhead on MSN
Health Check: Imagion is crossing the t’s and dotting the i’s on crucial breast imaging trial submission
Under the auspices of the US regulator, Imagion Biosystems hopes to launch a crucial phase II breast cancer imaging study by ...
Bayern Munich will go head-to-head against Pafos FC in the Champions League on Tuesday night as they travel to Cyprus for ...
For more than 60 years, the medical community has been refining the diagnosis of multiple sclerosis. The diagnosis of ...
As well as slowing disease progression by 75 percent at 36 months, the scientists found that neurofilament light protein (NfL)—a biomarker of neuronal damage—levels in spinal fluid were lower in ...
The Chicago Cubs were still evaluating the extent of starter Cade Horton's back injury, leaving the National League Rookie of ...
Their journeys, from diagnosis to recovery, are all very different, but these stars have something in common: They've spoken ...
News-Medical.Net on MSN
UCLA presents advances in radiation therapy at ASTRO 2025
Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and ...
Iopofosine I 131 is a potential first-in-class, novel cancer targeting agent utilizing a phospholipid ether as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results